Faeth Therapeutics is a Biotech company based in San Francisco Bay Area. It has raised $292M in total funding. Latest round: Growth.
Faeth Therapeutics funding overview
Faeth Therapeutics is a Biotech company based in San Francisco Bay Area. Faeth Therapeutics has raised $292M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Growth announced in February 2026. The round record for Faeth Therapeutics runs through 2026; nothing later has been disclosed. Investors on record include Khosla Ventures, Future Ventures, S2G Ventures. 3 distinct backers are named across the disclosed rounds.
Faeth Therapeutics at a glance
Total raised
$292M
Latest round
Growth
Latest round date
February 2026
Industry
Biotech
Headquarters
San Francisco Bay Area
Notable investors
Khosla Ventures, Future Ventures, S2G Ventures
Frequently asked about Faeth Therapeutics funding
How much has Faeth Therapeutics raised?
Faeth Therapeutics has raised $292M in total disclosed funding across the rounds on record.
Who has invested in Faeth Therapeutics?
Khosla Ventures, Future Ventures, S2G Ventures are named among the investors backing Faeth Therapeutics.
What was the latest Faeth Therapeutics funding round?
The most recent disclosed round is a Growth, announced in February 2026.
Where is Faeth Therapeutics based?
Faeth Therapeutics is based in San Francisco Bay Area.
What sector does Faeth Therapeutics operate in?
Faeth Therapeutics is tracked under Biotech from San Francisco Bay Area, with $292M in disclosed funding.
When did Faeth Therapeutics last raise?
The last disclosed Faeth Therapeutics round closed in February 2026 at Growth.
Round data for Faeth Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the Biotech companies in San Francisco Bay Area and backer lists below.
